SEARCH ARTICLES



LATEST ARTICLES

Table of Contents

2019 Month : August Volume : 8 Issue : 31 Page : 2462-2466

Vascular Endothelial Growth Factor (VEGF) Expression in Oral Cancer and its Correlation with Clinico-Pathological Parameters- A Prospective Study.

Ashish Singhal1, Rahat Hadi2, Charu Mahajan3, Nuzhat Husain4

1Professor and HOD, Department of Surgical Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
2Professor, Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences,
Lucknow, Uttar Pradesh, India.
3Ex-Senior Resident, Department of Surgical Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
4Professor and HOD, Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences,
Lucknow, Uttar Pradesh, India.

References :

1

Coelho KR. Challenges of the oral cancer burden in India. Article ID 701932, J Cancer Epidemiol 2012;2012:1-17. doi:10.1155/2012/701932          

CrossRef | Google Scholar |
2

Faratzis G, Tsiambas E, Rapdis AD, et al. VEGF and KI 67 expression in squamous cell carcinoma of tongue – an immunohistochemical and computerized image analysis study. Oral Oncol 2009;45(7):584-8.              

CrossRef | Google Scholar | PubMed
3

Ellis LM, Rosen L, Gordon MS. Overview of anti-VEGF therapy and angiogenesis. Part 1: angiogenesis inhibition in solid tumor malignancies. Clin Adv Hematol Oncol 2006;4(1):1-10.            

Google Scholar | PubMed
4

Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12(3-4):303-24.      

Google Scholar | PubMed
5

Shintani S, Li C, Ishikawa T, et al. Expression of vascular endothelial growth factor A, B, C and D in oral squamous cell carcinoma. Oral Oncol 2004;40(1):13-20.

CrossRef | Google Scholar | PubMed
6

Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267(16):10931-4.             

CrossRef | PubMed
7

Sherin N, Simi T, Shameena P, et al. Changing trend in oral cancer. Indian J of Cancer 2008;45(3):93-6.             

CrossRef | Google Scholar | PubMed
8

Iype EM, Pandey M, Mathew A, et al. Oral cancer among patients under the age of 35 years. Journal of Postgraduate Medicine 2001;47(3):171-6.     

CrossRef | Google Scholar | PubMed
9

Dinshaw KA, Rao DN. Hospital cancer registry annual report 1998, Mumbai: TMH 2002: p. 23-9.

10

Li YH, Hu CF, Shao Q, et al. Elevated expression of survival and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Journal of Translational Medicine 2008;6:1.    

CrossRef | Google Scholar | PubMed
11

Shang ZJ, Li JR. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma its correlation with angiogenesis and disease progression. J Oral Pathol Med 2005;34(3):134-9.          

CrossRef | Google Scholar | PubMed
12

Maeda T, Matsumura S, Hiranuma H, et al. Expression of vascular endothelial growth factors in human oral squamous cell carcinoma its association with tumor progression and p53 gene status. J Clin Pathol 1998;51(10):771-5.          

CrossRef | Google Scholar | PubMed
13

Smith BD, Smith GL, Carter D, et al. Prognostic significance of vascular endothelial growth factor level in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000;18(10):2046-52.            

CrossRef | Google Scholar | PubMed
14

Kyzas PA, Cunha IW, Ioannidis JP. Prognostic significance of VEGF immunohistochemical expression in head and neck squamous cell carcinoma – a meta-analysis. Clinical Cancer Research 2005;11(4):1434-40.              

CrossRef | PubMed